Adhezion Biomedical
Adhezion Biomedical is a US-based medical device manufacturer of surgical sealants, tissue adhesives, microbial sealants, catheter securement, and topical skin adhesives, serving medical professionals and medical device manufacturers. Acquired by H.B. Fuller in July 2023.
- Company typePrivate
- Founded2001
- HeadquartersReading, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Adhezion Biomedical does
Adhezion Biomedical is a US-based medical device manufacturer founded in 2001, specializing in surgical sealants, tissue adhesives, microbial sealants, catheter securement adhesives, and topical skin adhesives. Its product portfolio includes five branded lines — FloraSeal (microbial sealant), Glubran2 (surgical glue in 0.25ml, 0.5ml, and 1ml volumes), SecurePortIV (catheter securement), SurgiSeal and SurgiSeal Stylus (topical skin adhesives), and Histoacryl — serving clinical use cases spanning wound closure, vascular access, liquid embolics, preoperative sealing, and infection prevention. Manufacturing is conducted at a US facility in Hudson, North Carolina. The company operated as an independent entity for over two decades before being acquired by H.B. Fuller Company in July 2023 and integrated into its Medical Adhesive Technologies division.
The business model is B2B hardware sales of medical-grade adhesive products, sold directly to two customer segments: medical professionals (surgeons, physicians, healthcare providers) and medical device manufacturers requiring adhesive inputs for device assembly, stick-to-skin applications, PPE, and medical filtration. Pricing is quote-based and not publicly disclosed; distribution occurs through direct sales via phone and corporate website, now leveraging H.B. Fuller's global medical adhesive distribution network spanning North America, Europe, and Asia. The target market is the $8 billion healthcare adhesives sector.
Pre-acquisition, the company was venture-backed, having raised approximately $12.3 million across five disclosed financing rounds between 2008 and 2012, with investors including Liberty Venture Partners and Originate Ventures. Following the H.B. Fuller acquisition, Adhezion's product set is positioned within the parent's broader medical adhesive portfolio rather than as an independent growth platform, and standalone financial metrics are no longer separately disclosed.
Adhezion Biomedical firmographics
Firmographics- Name
- Adhezion Biomedical
- Legal name
- Adhezion Biomedical
- Website
- https://adhezion.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Adhezion Biomedical is a US-based medical device manufacturer of surgical sealants, tissue adhesives, microbial sealants, catheter securement, and topical skin adhesives, serving medical professionals and medical device manufacturers. Acquired by H.B. Fuller in July 2023.
- Ownership category
- akta.pro rank
Adhezion Biomedical industry classification
Industry- Product category
- Medical Adhesives
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Adhesive Manufacturing (32552)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Adhesives & Sealants (2891)
- akta.pro primary industry
- Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips) (HLAHALAD)
- akta.pro secondary industry
- Adhesives & Sealants Chemicals (IMAEABAA)
Keywords
Where Adhezion Biomedical is headquartered
LocationHeadquarters
- HQ city
- Reading
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Adhezion Biomedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Medical Adhesive Product Sales: Adhezion Biomedical generates revenue through the manufacture and sale of surgical sealants, tissue adhesives, and related medical adhesive products to healthcare facilities and medical device manufacturers. Following acquisition by H.B. Fuller, products are sold as part of H.B. Fuller's medical adhesive portfolio targeting the $8 billion healthcare adhesives sector.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Adhezion Biomedical product offering
Product offeringCore offering
Adhezion Biomedical manufactures and sells medical-grade adhesive products for surgical and wound care applications, including microbial sealants (FloraSeal), surgical glues (Glubran2), catheter securement adhesives (SecurePortIV), and topical skin adhesives (SurgiSeal/SurgiSeal Stylus, Histoacryl). The portfolio targets surgical wound closure, vascular access, infection prevention, and medical device assembly applications for medical professionals and medical device manufacturers.
Product overview
Adhezion Biomedical, acquired by H.B. Fuller in July 2023, operates under H.B. Fuller Medical Adhesive Technologies and offers a portfolio of specialized medical-grade adhesive products. The product lineup centers on surgical sealants and adhesives including FloraSeal (microbial sealant), Glubran2 (surgical glue available in multiple volumes), SecurePortIV (catheter securement adhesive), SurgiSeal and SurgiSeal Stylus (topical skin adhesives), and Histoacryl. These products serve medical professionals in wound closure, vascular access, and infection prevention applications, with the portfolio organized into internal and external medical-grade solutions covering wound closure, vascular access, liquid embolics, and infection control segments.
Differentiator
Problem solved
Functional benefit
Brands
- H.B. Fuller Medical Adhesive Technologies: A division of H.B. Fuller Company focused on medical-grade adhesive solutions including surgical sealants, tissue adhesives, catheter securement, and wound closure products.
Products and services
- FloraSeal® Microbial sealant product designed for medical professionals, providing antimicrobial barrier protection for wound care applications.
- Glubran®2 Surgical Glue Surgical glue available in multiple volumes (0.25ml, 0.5ml, 1ml) for tissue sealing and wound closure applications during surgical procedures.
- SecurePortIV® Catheter securement adhesive designed to safely and effectively secure intravascular catheters, reducing the risk of dislodgement.
- SurgiSeal Stylus® Topical skin adhesive delivery device (stylus format) for wound closure, providing a liquid adhesive for superficial wound sealing.
- SurgiSeal® Topical skin adhesive product for wound closure, enabling sterile sealing of minor cuts and surgical incisions.
- Histoacryl® Medical adhesive product for surgical and wound care applications.
Quantifiable outcome
- Acquired by H.B. Fuller in July 2023 to strengthen presence in the $8 billion healthcare adhesives sector
Companies that use Adhezion Biomedical
Customer profileSegments2 records
Ideal customer profiles2 records
Adhezion Biomedical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Adhezion Biomedical partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Adhezion Biomedical competitors and assessment
Company assessmentBroad incumbents
- 3M Health Care: Diversified medical products company with skin closure strips, dressings, and medical-grade adhesive solutions. Adjacent competitor to Adhezion's topical adhesives and stick-to-skin applications.
- Smith & Nephew: Large diversified wound care and surgical device company offering skin adhesives, dressings, and closure products. Broader portfolio but overlaps with Adhezion's topical skin adhesive and wound closure franchises.
Direct peers
- Baxter International: Markets Tisseel and Floseal surgical sealants/hemostats used in operating rooms. Overlaps directly with Adhezion's surgical sealant and tissue adhesive portfolio for internal surgical applications.
- Artivion (formerly CryoLife): Specializes in surgical sealants and hemostats including BioGlue. Competes with Adhezion's Glubran2 and surgical tissue adhesive lines in cardiothoracic and general surgery.
- Integra LifeSciences: Provides tissue adhesives, dural sealants, and wound care products. Overlaps with Adhezion's surgical sealants (Glubran2, FloraSeal) and catheter securement categories.
- B. Braun: Offers surgical tissue adhesives and wound closure products through its Aesculap division. Competes with Adhezion in surgical glues and wound closure solutions for hospitals and surgeons.
- Ethicon (Johnson & Johnson MedTech): Global leader in surgical tissue adhesives and topical skin adhesives (e.g., Dermabond). Directly competes with Adhezion's SurgiSeal and Glubran2 lines across surgical wound closure and topical applications.
- Medtronic: Markets Evicel and other surgical sealants/hemostats. Directly competes with Adhezion's surgical sealant portfolio in operating room and vascular applications.
Emerging players
- Cohera Medical: Focused on surgical adhesives and sealants, including tissue adhesives for internal use. Niche overlap with Adhezion's surgical glue portfolio for specific procedural indications.
- TissuePatch: Develops tissue adhesives and sealants for surgical applications. Comparable emerging competitor in the surgical sealant space where Adhezion's Glubran2 and FloraSeal compete.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Adhezion Biomedical social profiles
Digital presenceAdhezion Biomedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adhezion Biomedical leadership team
Management profileNumber of profiles
Profiles3 records
Adhezion Biomedical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adhezion Biomedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adhezion Biomedical
What does Adhezion Biomedical do?
Adhezion Biomedical manufactures and sells medical-grade adhesive products for surgical and wound care applications, including microbial sealants (FloraSeal), surgical glues (Glubran2), catheter securement adhesives (SecurePortIV), and topical skin adhesives (SurgiSeal/SurgiSeal Stylus, Histoacryl). The portfolio targets surgical wound closure, vascular access, infection prevention, and medical device assembly applications for medical professionals and medical device manufacturers.
Is Adhezion Biomedical a public or private company?
Adhezion Biomedical is a private company. It is classified as corporate owned and is currently acquired.
When was Adhezion Biomedical founded?
Adhezion Biomedical was founded in 2001. It employs 11 to 50 people.
Where is Adhezion Biomedical based?
Adhezion Biomedical is headquartered in Reading, United States, in the North America region.
How does Adhezion Biomedical make money?
One revenue line is on record: medical Adhesive Product Sales.
Who are Adhezion Biomedical's main competitors?
Broad incumbents on record are 3M Health Care and Smith & Nephew. Direct peers are Baxter International, Artivion (formerly CryoLife), Integra LifeSciences, B. Braun, Ethicon (Johnson & Johnson MedTech) and Medtronic. Emerging players are Cohera Medical and TissuePatch.
Does Adhezion Biomedical have an API?
No public API is recorded for Adhezion Biomedical.
What industry is Adhezion Biomedical in?
Adhezion Biomedical's product category is Medical Adhesives. Its primary akta.pro industry code is HLAHALAD, Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips), with a secondary code of IMAEABAA, Adhesives & Sealants Chemicals. Its NAICS code is 339113 and its SIC code is 3841.